Singh Raj Pal, Bhushan Manindra
Department of Physics, GLA University, Mathura, Uttar Pradesh, India.
Division of Medical Physics, Department of Radiation Oncology, Rajiv Gandhi Cancer Institute and Research Center, New Delhi, 110085, India.
Radiol Phys Technol. 2025 Sep 6. doi: 10.1007/s12194-025-00961-8.
This study compares the dosimetric performance of Base Dose Optimization (BDO) and Gradient-Based Optimization (GBO) for extended target volumes in Total Body Irradiation (TBI). The focus is on overlapping regions using the Rando Phantom. The study evaluates dose distribution, conformity, homogeneity, and sensitivity to positional deviations. The Rando Phantom was used for treatment planning with both BDO and GBO plans. Positional shifts of ± 5 mm and ± 10 mm were introduced to assess uncertainties. Dosimetric metrics included mean dose, minimum dose, maximum dose, homogeneity index (HI), and conformity index (CI). Positional deviations and their impact on dose variations were analyzed. Quality assurance was performed using OSLDs and an array detector. The BDO plan delivered higher mean doses (103.6%-108.7%) and hotspot values, with a maximum of 133.7%. In contrast, the GBO plan produced a more uniform dose distribution (99.6%-100.3%) with lower hotspots, peaking at 112%. The BDO plan achieved better uniformity (HI 0.025-0.103) and higher conformity (CI 0.938-0.981). The GBO plan showed greater variability (HI 0.143-0.253) and slightly lower conformity (CI 0.941-0.964). Positional shifts revealed that the BDO plan was highly sensitive, with overdoses of + 46.60% and underdoses of - 47.29%. The GBO plan showed smaller deviations (+ 11.62% overdose, - 11.73% underdose). Gamma analysis demonstrated higher pass rates for the GBO plan. The BDO plan excels in target coverage and conformity but is sensitive to positional shifts. The GBO plan offers better uniformity and robustness, supporting its use in complex clinical scenarios. Further refinement of both approaches could improve clinical applicability and patient outcomes.
本研究比较了全身照射(TBI)中扩展靶区的基础剂量优化(BDO)和基于梯度的优化(GBO)的剂量学性能。重点是使用兰多人体模型的重叠区域。该研究评估了剂量分布、适形性、均匀性以及对位置偏差的敏感性。兰多人体模型用于BDO和GBO计划的治疗计划。引入±5毫米和±10毫米的位置偏移以评估不确定性。剂量学指标包括平均剂量、最小剂量、最大剂量、均匀性指数(HI)和适形性指数(CI)。分析了位置偏差及其对剂量变化的影响。使用光激发发光剂量计(OSLD)和阵列探测器进行质量保证。BDO计划的平均剂量(103.6%-108.7%)和热点值更高,最高可达133.7%。相比之下,GBO计划产生的剂量分布更均匀(99.6%-100.3%),热点较低,峰值为112%。BDO计划实现了更好的均匀性(HI 0.025-0.103)和更高的适形性(CI 0.938-0.981)。GBO计划显示出更大的变异性(HI 0.143-0.253)和略低的适形性(CI 0.941-0.964)。位置偏移表明BDO计划高度敏感,过量46.60%,不足47.29%。GBO计划的偏差较小(过量11.62%,不足11.73%)。伽马分析表明GBO计划的通过率更高。BDO计划在靶区覆盖和适形性方面表现出色,但对位置偏移敏感。GBO计划提供了更好的均匀性和稳健性,支持其在复杂临床场景中的应用。两种方法的进一步完善可以提高临床适用性和患者治疗效果。